Accuray (ARAY) Short-term Investments (2012 - 2026)

Accuray (ARAY) posted quarterly Short-term Investments of $467000.0 for Q1 2026, down 60.15% quarter-over-quarter from $1.2 million in Q4 2025.

Accuray (ARAY) Short-term Investments (2012 - 2026) Analysis & Trends

Accuray's Short-term Investments history runs 10 years deep, the most recent figure standing at $467000.0 for Q1 2026.

In Q1 2026, Short-term Investments changed N/A year-over-year to $467000.0; the TTM figure through Mar 2026 stood at $467000.0 (changed N/A YoY), while the FY2024 annual figure was $485000.0, changed N/A from the prior year.
Short-term Investments for Q1 2026 stood at $467000.0, down from $1.2 million in the prior quarter.
The five-year high for Short-term Investments was $1.2 million in Q4 2025, with the low at $467000.0 in Q1 2026.
The 3-year median for Short-term Investments is $528500.0 (2024), against an average of $674000.0.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Accuray	35.28 Mn	-4.42 Mn	25.29 Mn

Download Data